QUAKERTOWN, PA, Mar 24, 2025 - (ACN Newswire) - DEXIS, the global leader in dental imaging technologies, is excited to announce its participation in the International...
Everest Medicines' stock (1952.HK) surged today, opening higher and maintaining strong momentum throughout the trading day. By market close, the stock had risen 20.12%...
– Data from the proof-of-concept study showed berberine ursodeoxycholate was generally well tolerated and had beneficial therapeutic effect in improving glycemic, hepatic and cardiometabolic...
Micreos Pharmaceuticals AG (Micreos), a preclinical-stage biopharmaceutical company, specializing in developing Engineered Endolysin therapies to target harmful pathogens that cause disease aggravation, has entered...
Rebranding heralds greater focus on building a future-ready global healthcare workforce
As it expands its mission to support healthcare workforce development on a global scale,...
Goldman Sachs’ latest report on China’s biotechnology sector highlights Everest Medicines (HKG: 1952) as a company on track to achieve EBITDA break-even by the...
Uncertain outlook for 2025 as new immigration policies are implemented
A new CGFNS International report indicates that a robust annual rate of nurse migration...
